{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:07:12Z","timestamp":1774580832581,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009853","name":"Dimbleby Cancer Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To evaluate the effectiveness of the symptom management after radiotherapy (SMaRT) group intervention to improve urinary symptoms in men with prostate cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The randomised controlled trial (RCT) recruited men from one radiotherapy centre in the UK after curative radiotherapy or brachytherapy and with moderate to severe urinary symptoms defined as scores \u2265 8 on the International Prostate Symptom Score (IPSS) questionnaire. Sixty-three men were randomised either; to SMaRT, a 10-week symptom-management intervention including group support, education, pelvic floor muscle exercises, or a care-as-usual group. The primary outcome was the IPSS at 6 months\u00a0from baseline assessment. Secondary outcomes were IPSS at 3 months, and International Continence Society Male Short Form (ICS), European Organisation for Research and Treatment of Cancer Quality of Life prostate scale (EORTC QLQ-PR25), EORTC QLQ-30 and Self-Efficacy for Symptom Control Inventory (SESCI) at 3 and 6 months from baseline. Analysis of covariance (ANCOVA) was used to analyse the effect of the intervention.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>SMaRT group intervention did not improve urinary symptoms as measured by IPSS at 6-months. The adjusted difference was \u2212 2.5 [95%CI \u2212 5.0 to 0.0], <jats:italic>p<\/jats:italic> = 0.054. Significant differences were detected at 3 months in ICS voiding symptoms (\u2212 1.1 [\u2212 2.0 to \u2212 0.2], <jats:italic>p<\/jats:italic> = 0.017), ICS urinary incontinence (\u2212 1.0 [\u2212 1.8 to \u2212 0.1], <jats:italic>p<\/jats:italic> = 0.029) and SESCI managing symptoms domain (13.5 [2.5 to 24.4], <jats:italic>p<\/jats:italic> = 0.017). No differences were observed at 6 months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>SMaRT group intervention provided short-term benefit in urinary voiding and continence and helped men manage symptoms but was not effective long term.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-021-06749-x","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T11:03:49Z","timestamp":1640084629000},"page":"3165-3176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Randomised controlled trial to investigate the effectiveness of the symptom management after radiotherapy (SMaRT) group intervention to ameliorate lower urinary tract symptoms in men treated for prostate cancer"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-0243","authenticated-orcid":false,"given":"Sara","family":"Faithfull","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Cockle-Hearne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Lemanska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Otter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon S.","family":"Skene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"key":"6749_CR1","unstructured":"Cancer Research UK Prostate Cancer survival statistics London\u00a02015-17. Available from:\u00a0https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/prostate-cancer. Accessed\u00a011 Aug 2021"},{"issue":"6","key":"6749_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394\u2013424","journal-title":"CA Cancer J Clin."},{"issue":"2","key":"6749_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jama.2019.20675","volume":"323","author":"KE Hoffman","year":"2020","unstructured":"Hoffman KE, Penson DF, Zhao Z, Huang L-C, Conwill R, Laviana AA et al (2020) Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer. JAMA. 323(2):149\u201363","journal-title":"JAMA."},{"key":"6749_CR4","doi-asserted-by":"publisher","first-page":"m3503","DOI":"10.1136\/bmj.m3503","volume":"371","author":"CG Mazariego","year":"2020","unstructured":"Mazariego CG, Egger S, King MT, Juraskova I, Woo H, Berry M et al (2020) Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study. BMJ. 371:m3503","journal-title":"BMJ."},{"issue":"3","key":"6749_CR5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/1878-0261.12428","volume":"13","author":"P Lagergren","year":"2019","unstructured":"Lagergren P, Schandl A, Aaronson NK, Adami HO, de Lorenzo F, Denis L et al (2019) Cancer survivorship: an integral part of Europe\u2019s research agenda. Mol Oncol. 13(3):624\u201335","journal-title":"Mol Oncol."},{"issue":"6B","key":"6749_CR6","doi-asserted-by":"publisher","first-page":"E36","DOI":"10.1111\/bju.13179","volume":"117","author":"S Carlsson","year":"2016","unstructured":"Carlsson S, Drevin L, Loeb S, Widmark A, Lissbrant IF, Robinson D et al (2016) Population-based study of long-term functional outcomes after prostate cancer treatment. BJU Int. 117(6B):E36-45","journal-title":"BJU Int."},{"issue":"1","key":"6749_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.juro.2012.08.091","volume":"189","author":"S Kim","year":"2013","unstructured":"Kim S, Moore DF, Shih W, Lin Y, Li H, Shao YH et al (2013) Severe genitourinary toxicity following radiation therapy for prostate cancer\u2013how long does it last? J Urol. 189(1):116\u201321","journal-title":"J Urol."},{"issue":"10","key":"6749_CR8","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1007\/s11136-019-02212-x","volume":"28","author":"S Wilding","year":"2019","unstructured":"Wilding S, Downing A, Wright P, Selby P, Watson E, Wagland R et al (2019) Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy. Qual Life Res. 28(10):2741\u201351","journal-title":"Qual Life Res."},{"issue":"6","key":"6749_CR9","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.ejon.2013.04.002","volume":"17","author":"C Paterson","year":"2013","unstructured":"Paterson C, Jones M, Rattray J, Lauder W (2013) Exploring the relationship between coping, social support and health-related quality of life for prostate cancer survivors: a review of the literature. Eur J Oncol Nurs. 17(6):750\u20139","journal-title":"Eur J Oncol Nurs."},{"issue":"2","key":"6749_CR10","first-page":"186","volume":"3","author":"D Liberman","year":"2014","unstructured":"Liberman D, Mehus B, Elliott SP (2014) Urinary adverse effects of pelvic radiotherapy. Transl Androl Urol. 3(2):186\u201395","journal-title":"Transl Androl Urol."},{"issue":"10","key":"6749_CR11","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/ijcp.12693","volume":"69","author":"S Faithfull","year":"2015","unstructured":"Faithfull S, Lemanska A, Aslet P, Bhatt N, Coe J, Drudge-Coates L et al (2015) Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies. Int J Clin Pract 69(10):1184\u2013208","journal-title":"Int J Clin Pract"},{"issue":"6","key":"6749_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.clon.2018.01.016","volume":"30","author":"A Lemanska","year":"2018","unstructured":"Lemanska A, Dearnaley DP, Jena R, Sydes MR, Faithfull S (2018) Older age, early symptoms and physical function are associated with the severity of late symptom clusters for men undergoing radiotherapy for prostate cancer. Clin Oncol (R Coll Radiol) 30(6):334\u2013345","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"24","key":"6749_CR13","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1200\/JCO.2008.18.6486","volume":"27","author":"RC Chen","year":"2009","unstructured":"Chen RC, Clark JA, Talcott JA (2009) Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. J Clin Oncol 27(24):3916\u201322","journal-title":"J Clin Oncol"},{"issue":"2","key":"6749_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.brachy.2020.10.002","volume":"20","author":"N Groom","year":"2021","unstructured":"Groom N, Tsang Y, Lowe G, Hoskin P (2021) Risk factors for urethral stricture following external beam radiotherapy and HDR brachytherapy for prostate cancer. Brachytherapy 20(2):302\u2013306","journal-title":"Brachytherapy"},{"issue":"5","key":"6749_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/tre.119","volume":"14","author":"A Tree","year":"2009","unstructured":"Tree A, Khoo V (2009) Treatment of early prostate cancer: radiotherapy, including brachytherapy. Trends Urol Gynaecol Sex Health. 14(5):18\u201323","journal-title":"Trends Urol Gynaecol Sex Health."},{"issue":"12","key":"6749_CR16","doi-asserted-by":"publisher","first-page":"e775","DOI":"10.1016\/j.ejrad.2013.09.011","volume":"82","author":"C Marigliano","year":"2013","unstructured":"Marigliano C, Donati OF, Vargas HA, Akin O, Goldman DA, Eastham JA et al (2013) MRI findings of radiation-induced changes in the urethra and periurethral tissues after treatment for prostate cancer. Eur J Radiol. 82(12):e775-81","journal-title":"Eur J Radiol."},{"issue":"2","key":"6749_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41391-017-0028-3","volume":"21","author":"MA Awad","year":"2018","unstructured":"Awad MA, Gaither TW, Osterberg EC, Murphy GP, Baradaran N, Breyer BN (2018) Prostate cancer radiation and urethral strictures: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 21(2):168\u201374","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"Suppl 3","key":"6749_CR18","first-page":"S148","volume":"39","author":"R Bosch","year":"2020","unstructured":"Bosch R, McCloskey K, Bahl A, Arlandis S, Ockrim J, Weiss J et al (2020) Can radiation-induced lower urinary tract disease be ameliorated in patients treated for pelvic organ cancer: ICI-RS 2019? Neurourol Urodyn. 39(Suppl 3):S148\u2013S55","journal-title":"Neurourol Urodyn."},{"issue":"2","key":"6749_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11764-015-0481-8","volume":"10","author":"S Bernard","year":"2016","unstructured":"Bernard S, Ouellet MP, Moffet H, Roy JS, Dumoulin C (2016) Effects of radiation therapy on the structure and function of the pelvic floor muscles of patients with cancer in the pelvic area: a systematic review. J Cancer Surviv. 10(2):351\u201362","journal-title":"J Cancer Surviv."},{"key":"6749_CR20","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1038\/bjc.2013.679","volume":"109","author":"K Dieperink","year":"2013","unstructured":"Dieperink K, Johansen C, Hansen S, Wagner L, Anderson K, Minet L et al (2013) The effects of multidisciplinary rehabilitation: RePCa- a randomnised study among primary prostate cancer patients. Br J Cancer. 109:3005\u201313","journal-title":"Br J Cancer."},{"key":"6749_CR21","unstructured":"de Longh A, Fagan P, Fenner J, Kidd L (2015) A practical guide to self-management support. 90 Long Acre, London, WC2E 9RA: The Health Foundation. Contract No.: ISBN 978-1-906481-74-4"},{"issue":"11","key":"6749_CR22","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/pon.5215","volume":"28","author":"CA Cuthbert","year":"2019","unstructured":"Cuthbert CA, Farragher JF, Hemmelgarn BR, Ding Q, McKinnon GP, Cheung WY (2019) Self-management interventions for cancer survivors: a systematic review and evaluation of intervention content and theories. Psycho-Oncol. 28(11):2119\u201340","journal-title":"Psycho-Oncol."},{"issue":"5","key":"6749_CR23","first-page":"1585","volume":"26","author":"L Boland","year":"2018","unstructured":"Boland L, Bennett K, Connolly D (2018) Self-management interventions for cancer survivors: a systematic review. Support Care Cancer. 26(5):1585\u201395","journal-title":"Support Care Cancer."},{"issue":"6","key":"6749_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1188\/17.ONF.719-728","volume":"44","author":"SH Kim","year":"2017","unstructured":"Kim SH, Kim K, Mayer DK (2017) Self-management intervention for adult cancer survivors after treatment: a systematic review and meta-analysis. Oncol Nurs Forum. 44(6):719\u201328","journal-title":"Oncol Nurs Forum."},{"issue":"5","key":"6749_CR25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1464-410X.2010.09588.x","volume":"107","author":"S Faithfull","year":"2011","unstructured":"Faithfull S, Cockle-Hearne J, Khoo V (2011) Self-management after prostate cancer treatment: evaluating the feasibility of providing a cognitive and behavioural programme for lower urinary tract symptoms. BJU Int. 107(5):783\u201390","journal-title":"BJU Int."},{"key":"6749_CR26","volume-title":"Cancer rehabilitation pathways","author":"Macmillan Cancer Support","year":"2018","unstructured":"Macmillan Cancer Support (2018) Cancer rehabilitation pathways. Macmillan Cancer Support, London"},{"issue":"2","key":"6749_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3322\/caac.21639","volume":"71","author":"NL Stout","year":"2021","unstructured":"Stout NL, Santa Mina D, Lyons KD, Robb K, Silver JK (2021) A systematic review of rehabilitation and exercise recommendations in oncology guidelines. CA Cancer J Clin. 71(2):149\u201375","journal-title":"CA Cancer J Clin."},{"issue":"4","key":"6749_CR28","doi-asserted-by":"publisher","first-page":"151048","DOI":"10.1016\/j.soncn.2020.151048","volume":"36","author":"C Paterson","year":"2020","unstructured":"Paterson C, Roberts C, Toohey K, McKie A (2020) Prostate cancer prehabilitation and the importance of multimodal interventions for person-centred care and recovery. Semin Oncol Nurs. 36(4):151048","journal-title":"Semin Oncol Nurs."},{"issue":"1","key":"6749_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11764-014-0384-0","volume":"9","author":"C Foster","year":"2015","unstructured":"Foster C, Breckons M, Cotterell P, Barbosa D, Calman L, Corner J et al (2015) Cancer survivors\u2019 self-efficacy to self-manage in the year following primary treatment. J Cancer Surviv. 9(1):11\u20139","journal-title":"J Cancer Surviv."},{"issue":"4","key":"6749_CR30","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00520-015-2938-8","volume":"24","author":"J Cockle-Hearne","year":"2016","unstructured":"Cockle-Hearne J, Cooke D, Faithfull S (2016) Developing peer support in film for cancer self-management: what do men want other men to know? Support Care Cancer. 24(4):1625\u201331","journal-title":"Support Care Cancer."},{"key":"6749_CR31","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","volume":"148","author":"MJ Barry","year":"1992","unstructured":"Barry MJ, Fowler Jnr FJ, O\u2019Leary MP, Bruskewitch RC, Holtgrewe HL, Mebust WK et al (1992) The American Urological Association Symptom Index for Benign Prostatic Hyperplasia: The Measurement Committee of the American Urological Association. J Urol. 148:1549\u201357","journal-title":"J Urol."},{"issue":"6","key":"6749_CR32","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0022-5347(05)66926-1","volume":"164","author":"JL Donovan","year":"2000","unstructured":"Donovan JL, Peters TJ, Abrams P, Brookess ST, de la Rosette JJMCH, Schafer W (2000) Scoring the Short Form ICSmaleSF Questionnaire: International Continence Society. J Urol 164(6):1948\u201355","journal-title":"J Urol"},{"key":"6749_CR33","doi-asserted-by":"crossref","unstructured":"Whistance RN, Conroy T, Chie W, Costantini A, Sezer O, Koller M, et al. (2009) Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. European Journal Of Cancer (Oxford, England: 1990) 45(17):3017\u201326","DOI":"10.1016\/j.ejca.2009.08.014"},{"issue":"5","key":"6749_CR34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jpainsymman.2004.02.020","volume":"28","author":"LC Campbell","year":"2004","unstructured":"Campbell LC, Keefe FJ, McKee DC, Edwards CL, Herman SH, Johnson LE et al (2004) Prostate cancer in African Americans: relationship of patient and partner self-efficacy to quality of life. J Pain Symptom Manage. 28(5):433\u201344","journal-title":"J Pain Symptom Manage."},{"issue":"7","key":"6749_CR35","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/nau.23593","volume":"37","author":"LM Hall","year":"2018","unstructured":"Hall LM, Aljuraifani R, Hodges PW (2018) Design of programs to train pelvic floor muscles in men with urinary dysfunction: systematic review. Neurourol Urodyn. 37(7):2053\u201387","journal-title":"Neurourol Urodyn."},{"issue":"15","key":"6749_CR36","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1200\/JCO.18.01770","volume":"37","author":"TA Skolarus","year":"2019","unstructured":"Skolarus TA, Metreger T, Wittmann D, Hwang S, Kim HM, Grubb RL 3rd et al (2019) Self-management in long-term prostate cancer survivors: a randomized, controlled trial. J Clin Oncol. 37(15):1326\u201335","journal-title":"J Clin Oncol."},{"issue":"5","key":"6749_CR37","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s11764-020-00958-9","volume":"15","author":"KB Dieperink","year":"2021","unstructured":"Dieperink KB, Hansen S, Wagner L, Minet LR, Hansen O (2021) Long-term follow-up 3 years after a randomized rehabilitation study among radiated prostate cancer survivors. J Cancer Surviv 15(5):668\u2013676","journal-title":"J Cancer Surviv"},{"issue":"3","key":"6749_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.urolonc.2019.06.018","volume":"38","author":"KB Zuniga","year":"2020","unstructured":"Zuniga KB, Chan JM, Ryan CJ, Kenfield SA (2020) Diet and lifestyle considerations for patients with prostate cancer. Urol Oncol. 38(3):105\u201317","journal-title":"Urol Oncol."},{"issue":"4","key":"6749_CR39","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s11136-019-02361-z","volume":"29","author":"MJM Geerkens","year":"2020","unstructured":"Geerkens MJM, Pouwels NSA, Beerlage HP (2020) The effectiveness of lifestyle interventions to reduce side effects of androgen deprivation therapy for men with prostate cancer: a systematic review. Qual Life Res. 29(4):843\u201365","journal-title":"Qual Life Res."},{"issue":"2","key":"6749_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1370\/afm.2609","volume":"19","author":"L Albarqouni","year":"2021","unstructured":"Albarqouni L, Sanders S, Clark J, Tikkinen KAO, Glasziou P (2021) Self-management for men with lower urinary tract symptoms: a systematic review and meta-analysis. Ann Fam Med. 19(2):157\u201367","journal-title":"Ann Fam Med."},{"issue":"1","key":"6749_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11764-016-0557-0","volume":"11","author":"A Zhang","year":"2017","unstructured":"Zhang A, Fu A, Moore S, Zhu H, Strauss G, Kresevic D et al (2017) Is a behavioral treatment for urinary incontinence beneficial to prostate cancer survivors as a follow-up care? J Cancer Survivorship 11(1):24\u201331","journal-title":"J Cancer Survivorship"},{"key":"6749_CR42","unstructured":"NICE (2019) Prostate cancer: diagnosis and management. London: National Institute for Clinical Evidence. Contract No.: ng131"},{"issue":"3","key":"6749_CR43","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1470-2045(18)30780-0","volume":"20","author":"A Downing","year":"2019","unstructured":"Downing A, Wright P, Hounsome L, Selby P, Wilding S, Watson E et al (2019) Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Lancet Oncol. 20(3):436\u201347","journal-title":"Lancet Oncol."},{"issue":"1","key":"6749_CR44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12885-019-5561-0","volume":"19","author":"J Frankland","year":"2019","unstructured":"Frankland J, Brodie H, Cooke D, Foster C, Foster R, Gage H et al (2019) Follow-up care after treatment for prostate cancer: evaluation of a supported self-management and remote surveillance programme. BMC Cancer. 19(1):368","journal-title":"BMC Cancer."},{"issue":"9","key":"6749_CR45","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.urolonc.2017.05.008","volume":"35","author":"TA Skolarus","year":"2017","unstructured":"Skolarus TA, Wittmann D, Hawley ST (2017) Enhancing prostate cancer survivorship care through self-management. Urol Oncol. 35(9):564\u20138","journal-title":"Urol Oncol."},{"issue":"3","key":"6749_CR46","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jmir.2019.03.182","volume":"50","author":"M Bowler","year":"2019","unstructured":"Bowler M, Dehek R, Thomas E, Ngo K, Grose L (2019) Evaluating the impact of post-treatment self-management guidelines for prostate cancer survivors. J Med Imaging Radiat Sci. 50(3):398\u2013407","journal-title":"J Med Imaging Radiat Sci."}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-021-06749-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T21:08:16Z","timestamp":1676149696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-021-06749-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["6749"],"URL":"https:\/\/doi.org\/10.1007\/s00520-021-06749-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,21]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial received a favourable ethical opinion from the National Research Ethics (UK) registration 10\/H1109\/55 and the University of Surrey Ethics Committee. It was registered with the National Institute of Health, UK Clinical Research Network ID 9433, and with ISRCTN Registration Number 20069765.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participates in the research were invited either by a member of the clinical team or through a letter from their clinical oncologist during or after radiotherapy treatment. Patient information sheets were provided to participants and patient written consent was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S.F. is a trustee of PCUK and chair of NCRI late consequences research group. All other authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}